A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913

Author:

Chinnaiyan Prakash1,Won Minhee2,Wen Patrick Y3,Rojiani Amyn M4,Werner-Wasik Maria5,Shih Helen A6,Ashby Lynn S7,Michael Yu Hsiang-Hsuan8,Stieber Volker W9,Malone Shawn C10,Fiveash John B11,Mohile Nimish A12,Ahluwalia Manmeet S13,Wendland Merideth M14,Stella Philip J15,Kee Andrew Y16,Mehta Minesh P17

Affiliation:

1. William Beaumont Hospital, Royal Oak, Michigan, USA

2. NRG Oncology Statistics and Data Management Center, Philadelphia, Pennsylvania, USA

3. Dana-Farber/Harvard Cancer Center, Boston, Massachusetts, USA

4. Augusta University–Medical College of Georgia, Augusta, Georgia, USA

5. Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA

6. Massachusetts General Hospital, Boston, Massachusetts, USA

7. Barrow Neurological Institute accruals under Arizona Oncology Services Foundation, Phoenix, Arizona, USA

8. H. Lee Moffitt Cancer, Tampa, Florida, USA

9. Novant Health Forsyth Regional Cancer Center accruals under Southeast Cancer Control Consortium, Inc, CCOP, Goldsboro, North Carolina, USA

10. The Ottawa Hospital Regional Cancer Centre, Ottawa, Ontario, Canada

11. University of Alabama at Birmingham Medical Center, Birmingham, Alabama, USA

12. University of Rochester, Rochester, New York, USA

13. Cleveland Clinic Foundation, Cleveland, Ohio, USA

14. Willamette Valley Cancer Institute, Eugene, Oregon, USA

15. Saint Joseph Mercy Hospital accruals under Michigan Cancer Research Consortium CCOP, Ypsilanti, Michigan, USA

16. Legacy Health Systems accruals under Mayo Clinic, Portland, Oregon, USA

17. Baptist Hospital of Miami, Miami, Florida, USA

Funder

National Cancer Institute

NRG Oncology Operations

Novartis

NRG Oncology SDMC

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Neurology (clinical),Oncology

Reference36 articles.

1. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008–2012;Ostrom;Neuro Oncol,2015

2. Malignant gliomas in adults;Wen;N Engl J Med,2008

3. Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial;Gilbert;J Clin Oncol,2013

4. TCGA: comprehensive genomic characterization defines human glioblastoma genes and core pathways;Cancer Genome Atlas Research Network;Nature,2008

5. Analysis of the phosphatidylinositol 3ʹ-kinase signaling pathway in glioblastoma patients in vivo;Choe;Cancer Res,2003

Cited by 106 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3